Last reviewed: June 30, 2026

Last updated: June 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by slowing stomach emptying and reducing hunger signals in the brain, making it essential to start at the right dose for your body. Most patients begin at 0.25 mg weekly, then gradually increase based on tolerance and response. PlexusDx compounded semaglutide injections help you navigate this journey with clinical support and transparent, flat monthly pricing that doesn't change as your dose adjusts.

Understanding Semaglutide Dose Escalation Protocols

Semaglutide follows a dose-escalation schedule designed to let your body adapt gradually. The typical titration begins at 0.25 mg once weekly for four weeks, then increases by 0.25 mg each month until reaching your therapeutic dose. This step-wise approach reduces nausea, vomiting, and gastrointestinal side effects that can occur if doses jump too quickly. Clinical trials show that slower escalation improves medication adherence and long-term weight loss outcomes.

Your starting dose depends on several factors, including your current weight, metabolic health, medication history, and any gastrointestinal sensitivities. A healthcare provider will review these elements to recommend whether you begin at the standard 0.25 mg or adjust your timeline. Some patients with sensitive stomachs may benefit from an even more gradual approach, while others tolerate faster increases. PlexusDx clinicians evaluate your individual profile before your first injection to set realistic expectations.

Typical Semaglutide Weekly Dose Progression Timeline

Week 1–4: Most patients inject 0.25 mg once weekly. During this phase, you may notice reduced appetite and mild nausea as your body adjusts. Weight loss at this stage is usually modest, 1–3 pounds per week, but metabolic benefits begin immediately. Keeping a simple food and symptom diary helps you track how your body responds.

Month 2: Your dose increases to 0.5 mg weekly. Appetite suppression typically deepens, and many patients report improved food satisfaction with smaller portions. Weight loss often accelerates to 3–5 pounds per week for those following consistent nutrition and activity habits. If side effects remain mild or absent, you're on track for the next increase.

Month 3 onward: Doses advance in 0.25 mg increments—0.75 mg, then 1.0 mg, and up to 2.4 mg weekly for maximum effect. Most people reach their optimal dose between 1.0 and 2.4 mg, where appetite suppression stabilizes without intolerable side effects. Your PlexusDx provider monitors your progress monthly and adjusts timing based on your experience, not a preset calendar.

How Genetic Testing Informs Your Personalized Starting Dose

PlexusDx offers the Precision Peptide Genetic Test, which identifies variations in genes that influence how your body responds to GLP-1 receptor agonists like semaglutide. Key genetic markers—including GLP1R rs6923761 and GIPR rs1800437—affect receptor sensitivity, medication metabolism, and hunger-pathway regulation. Knowing your genetic profile helps clinicians predict whether you're likely to benefit from a faster escalation, a slower climb, or a modified dosing strategy.

The Precision Peptide Genetic Test maps 14 metabolic pathways across 49 peptides, revealing 150+ personalized insights about your weight management biology. For instance, certain FTO rs9939609 variants are associated with stronger appetite signals, suggesting you may see earlier benefits at slightly higher doses. This genetic roadmap, available as a $99 add-on after your first month of treatment, transforms dosing from one-size-fits-all to truly personalized. Combined with clinical observation, genetic data helps PlexusDx providers fine-tune your protocol for faster results and fewer side effects.

Managing Side Effects While Optimizing Your Dose

Nausea is the most common side effect, especially during dose increases, and typically resolves within days as your body adjusts. Eating smaller, frequent meals rich in protein; staying hydrated; and avoiding fatty or high-sugar foods significantly reduce nausea severity. If side effects persist beyond one week, inform your PlexusDx clinician—they may slow your escalation or pause at your current dose for an extra week. Never stop injecting without guidance, as abrupt discontinuation can cause rapid appetite return and rebound weight gain.

Constipation develops in some patients because semaglutide slows gastrointestinal movement. Gentle fiber intake, regular movement, and adequate water intake prevent this. Other uncommon effects include mild headache, fatigue, or diarrhea, which usually resolve as your body stabilizes at a new dose level. Your monthly check-ins with PlexusDx ensure side effects don't derail your progress; if they do, dose adjustments preserve your safety and motivation.

Why PlexusDx Pricing Stays Flat Regardless of Your Dose Level

PlexusDx compounded semaglutide injections start at $149 per month—a flat rate that remains the same whether you're at 0.25 mg or your full therapeutic dose. Unlike other services that charge per dose or tier dosing into higher price brackets, PlexusDx eliminates financial barriers to reaching your optimal dose. This transparent model means you'll never hesitate to increase your dose due to cost concerns, and your monthly budget stays predictable.

All PlexusDx medications come from licensed 503A compounding pharmacies, ensuring clinical-grade quality without pharmacy markups at each dose change. The service is available in all 50 states, requires no insurance or membership fee, and qualifies for HSA and FSA accounts. When you're ready to adjust your semaglutide dose upward, you're only changing the injection, not your payment—a design philosophy that prioritizes your health outcome over profit-maximizing pricing schemes.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the most common starting dose for semaglutide weight loss treatment?

Most patients begin at 0.25 mg injected once weekly, held for four weeks before increasing. This cautious start allows your stomach and appetite-control system to adapt, reducing nausea and improving long-term adherence. PlexusDx providers adjust this timeline based on your health history and tolerance.

How fast will I lose weight on semaglutide, and when does it begin?

Weight loss typically starts in week 1–2, averaging 1–3 pounds per week at the 0.25 mg dose, then accelerating to 3–5+ pounds weekly as you reach therapeutic doses (1.0–2.4 mg). Results depend on your nutrition, activity level, and starting weight. Clinical trials show average 15% body weight reduction over 68 weeks at the 2.4 mg dose.

How much does PlexusDx semaglutide cost, and does the price increase with higher doses?

PlexusDx compounded semaglutide injections start at $149 per month, flat across all dose levels. Your dose may increase, but your price won't, eliminating cost barriers to reaching your optimal therapeutic level. The service is available nationwide without insurance, and HSA/FSA accounts apply.

What are the most common side effects during dose escalation, and how long do they last?

Nausea is most common and usually fades within 3–7 days as your body adjusts. Constipation, mild fatigue, and loss of appetite for foods you once enjoyed can occur. Eating smaller meals, staying hydrated, and gentle fiber intake manage most side effects. Inform your PlexusDx clinician if effects persist beyond one week—they may pause your escalation temporarily.

How does the PlexusDx Precision Peptide Genetic Test help with semaglutide dosing?

The Precision Peptide Genetic Test ($99 add-on) identifies key variants in GLP1R, GIPR, FTO, and MC4R genes that influence your appetite regulation and medication response. This genetic roadmap helps PlexusDx clinicians predict whether you'll benefit from faster escalation or a slower approach, personalizing your dosing strategy for faster results and fewer side effects.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves